Myeloid cell-associated aromatic amino acid metabolism facilitates CNS myelin regeneration
Jingwen Hu,George S. Melchor,Dimitrios Ladakis,Joan Reger,Hee Won Kim,Kelly A. Chamberlain,Nataliia V. Shults,Helena C. Oft,Victoria N. Smith,Lauren M. Rosko,Erqiu Li,Maryna Baydyuk,Meng-Meng Fu,Pavan Bhargava,Jeffrey K. Huang
DOI: https://doi.org/10.1038/s41536-023-00345-9
IF: 14.404
2024-01-02
npj Regenerative Medicine
Abstract:Abstract Regulation of myeloid cell activity is critical for successful myelin regeneration (remyelination) in demyelinating diseases, such as multiple sclerosis (MS). Here, we show aromatic alpha-keto acids (AKAs) generated from the amino acid oxidase, interleukin-4 induced 1 (IL4I1), promote efficient remyelination in mouse models of MS. During remyelination, myeloid cells upregulated the expression of IL4I1. Conditionally knocking out IL4I1 in myeloid cells impaired remyelination efficiency. Mice lacking IL4I1 expression exhibited a reduction in the AKAs, phenylpyruvate, indole-3-pyruvate, and 4-hydroxyphenylpyruvate, in remyelinating lesions. Decreased AKA levels were also observed in people with MS, particularly in the progressive phase when remyelination is impaired. Oral administration of AKAs modulated myeloid cell-associated inflammation, promoted oligodendrocyte maturation, and enhanced remyelination in mice with focal demyelinated lesions. Transcriptomic analysis revealed AKA treatment induced a shift in metabolic pathways in myeloid cells and upregulated aryl hydrocarbon receptor activity in lesions. Our results suggest myeloid cell-associated aromatic amino acid metabolism via IL4I1 produces AKAs in demyelinated lesions to enable efficient remyelination. Increasing AKA levels or targeting related pathways may serve as a strategy to facilitate the regeneration of myelin in inflammatory demyelinating conditions.
cell & tissue engineering,engineering, biomedical